HNSBF   $5.2  -2.22% Market Closed

Hansa Biopharma AB
Total Cash 553.54M
totalCashPerShare 8.163
EBITDA -623.31M
Total Debt 959.19M
quickRatio 2.445
currentRatio 2.451
Total Revenue 189.39M
debtToEquity
Revenue/Share 3.208
ROA -0.37081
ROE
grossProfits
freeCashflow -454.15M
operatingCashflow -700.03M
earningsGrowth
revenueGrowth 1.131
grossMargins 0.53433996
ebitdaMargins 0.0
operatingMargins -2.40276
profitMargins 0.0
enterpriseValue 653.17M
forwardPE
floatShares 38.23M
sharesOutstanding 65.61M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.09%
heldPercentInstitutions 0.41%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -4.718
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -654.78M
trailingEps -1.03%
forwardEps
enterpriseToEbitda -1.05
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 17
lastUpdated Nov. 7, 2024, 11 a.m.